164 related articles for article (PubMed ID: 37076912)
1. Five-mer peptides prevent short-term spatial memory deficits in Aβ25-35-induced Alzheimer's model mouse by suppressing Aβ25-35 aggregation and resolving its aggregate form.
Nakamura R; Konishi M; Higashi Y; Saito M; Akizawa T
Alzheimers Res Ther; 2023 Apr; 15(1):83. PubMed ID: 37076912
[TBL] [Abstract][Full Text] [Related]
2. Compound danshen tablet ameliorated aβ25-35-induced spatial memory impairment in mice via rescuing imbalance between cytokines and neurotrophins.
Teng Y; Zhang MQ; Wang W; Liu LT; Zhou LM; Miao SK; Wan LH
BMC Complement Altern Med; 2014 Jan; 14():23. PubMed ID: 24422705
[TBL] [Abstract][Full Text] [Related]
3. Preventive Effect of Betaine Against Cognitive Impairments in Amyloid β Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
Ibi D; Kondo S; Ohmi A; Kojima Y; Nakasai G; Takaba R; Hiramatsu M
Neurochem Res; 2022 Aug; 47(8):2333-2344. PubMed ID: 35597887
[TBL] [Abstract][Full Text] [Related]
4. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
Meunier J; Villard V; Givalois L; Maurice T
Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
[TBL] [Abstract][Full Text] [Related]
5. Neuronal seipin knockout facilitates Aβ-induced neuroinflammation and neurotoxicity via reduction of PPARγ in hippocampus of mouse.
Qian Y; Yin J; Hong J; Li G; Zhang B; Liu G; Wan Q; Chen L
J Neuroinflammation; 2016 Jun; 13(1):145. PubMed ID: 27287266
[TBL] [Abstract][Full Text] [Related]
6. Wnt-5a prevents Aβ-induced deficits in long-term potentiation and spatial memory in rats.
Zhang GL; Zhang J; Li SF; Lei L; Xie HY; Deng F; Feng JC; Qi JS
Physiol Behav; 2015 Oct; 149():95-100. PubMed ID: 26032671
[TBL] [Abstract][Full Text] [Related]
7. Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation.
Lee AY; Lee MH; Lee S; Cho EJ
J Agric Food Chem; 2017 Dec; 65(49):10719-10729. PubMed ID: 29092397
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease.
Li J; Liu CN; Wei N; Li XD; Liu YY; Yang R; Jia YJ
Brain Res; 2016 Jul; 1642():327-335. PubMed ID: 27071547
[TBL] [Abstract][Full Text] [Related]
9. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
10. Ameliorating effects of HX106N, a water-soluble botanical formulation, on Aβ25-35-induced memory impairment and oxidative stress in mice.
Lee DS; Choi J; Kim SH; Kim S
Biol Pharm Bull; 2014; 37(6):954-60. PubMed ID: 24694662
[TBL] [Abstract][Full Text] [Related]
11. Optimal Formula of Angelica sinensis Ameliorates Memory Deficits in β-amyloid Protein-induced Alzheimer's Disease Rat Model.
Wang HP; Wu HY; Ma CL; Zeng QT; Zhu KM; Cui SM; Li HL; Wu GT; Wu ZW; He JZ
Curr Med Sci; 2022 Feb; 42(1):39-47. PubMed ID: 35122611
[TBL] [Abstract][Full Text] [Related]
12. Rubrofusarin inhibits Aβ aggregation and ameliorates memory loss in an Aβ-induced Alzheimer's disease-like mouse model.
Cho E; Cai M; Kwon H; Jeon J; Moon M; Jun M; Lee YC; Yi JH; Ryu JH; Kim DH
Food Chem Toxicol; 2019 Oct; 132():110698. PubMed ID: 31348966
[TBL] [Abstract][Full Text] [Related]
13. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.
Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812
[TBL] [Abstract][Full Text] [Related]
14. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
[TBL] [Abstract][Full Text] [Related]
15. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
[TBL] [Abstract][Full Text] [Related]
16. Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
Choi YY; Maeda T; Fujii H; Yokozawa T; Kim HY; Cho EJ; Shibamoto T
Nutr Res; 2014 Jul; 34(7):595-603. PubMed ID: 25150118
[TBL] [Abstract][Full Text] [Related]
17. Octovespin, a peptide bioinspired by wasp venom, prevents cognitive deficits induced by amyloid-β in Alzheimer's disease mouse model.
Camargo LC; Veras LG; Vaz G; Souza ACB; Mortari MR
Neuropeptides; 2022 Jun; 93():102233. PubMed ID: 35305448
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of peptides extracted from walnut (Juglans Sigilata Dode) proteins on Aβ25-35-induced memory impairment in mice.
Zou J; Cai PS; Xiong CM; Ruan JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):21-30. PubMed ID: 26838735
[TBL] [Abstract][Full Text] [Related]
19. Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation.
Mokhtari Z; Baluchnejadmojarad T; Nikbakht F; Mansouri M; Roghani M
Biomed Pharmacother; 2017 Mar; 87():135-144. PubMed ID: 28049095
[TBL] [Abstract][Full Text] [Related]
20. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
